(Q33582990)

28 July 2017

title

Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

Feng-Juan Gao

1

1 reference

28 July 2017

Jie-Yu Chen

2

1 reference

28 July 2017

Hong-Yan Wu

3

1 reference

28 July 2017

Jiong Shi

4

1 reference

28 July 2017

Ming Chen

5

1 reference

28 July 2017

Xiang-Shan Fan

6

1 reference

28 July 2017

Qin Huang

7

1 reference

28 July 2017

publication date

15 March 2014

1 reference

International Journal of Clinical and Experimental Pathology

28 July 2017

published in

1 reference

28 July 2017

volume

7

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

1572-1579

1 reference

Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

The spatial distribution of LGR5+ cells correlates with gastric cancer progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Use of multiple biomarkers for the localization and characterization of colon cancer stem cells by indirect immunocytochemistry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Expression of HER2 in colorectal cancer does not correlate with prognosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

G protein-coupled receptors: novel targets for drug discovery in cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

erbB2 is required for G protein-coupled receptor signaling in the heart

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

The HER receptor family: a rich target for therapeutic development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

In situ validation of an intestinal stem cell signature in colorectal cancer

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014237

Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24817953

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24817953

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significance of Lgr5(+ve) cancer stem cells in the colon and rectum

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24817953

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

4014237

1 reference

28 July 2017

1 reference